HEADER ISOMERASE 27-NOV-23 8R7T TITLE CRYSTAL STRUCTURE OF CYCLOPHILIN TGCYP23 FROM TOXOPLASMA GONDII IN TITLE 2 COMPLEX WITH ALISPORIVIR (NONIMMUNOSUPPRESSIVE ANALOGUE OF TITLE 3 CYCLOSPORIN) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: PPIASE; COMPND 5 EC: 5.2.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THERE ARE TWO ADDITIONAL RESIDUES IN N-TERM, THAT COMPND 8 REMAIN AFTER THE HIS TAG CLEAVAGE AND ARE NOT OBSERVED IN DENSITY. COMPND 9 GLYCINE (-1) HISTIDINE (0); COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: ALISPORIVIR; COMPND 12 CHAIN: C, D; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 5811; SOURCE 4 GENE: TGRH88_026260; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630 KEYWDS CYCLOPHILIN COMPLEX, PEPTIDYLPROLYL ISOMERASE ACTIVITY, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.JIMENEZ-FARACO,J.A.HERMOSO REVDAT 1 30-OCT-24 8R7T 0 JRNL AUTH F.FAVRETTO,E.JIMENEZ-FARACO,G.CATUCCI,A.DI MATTEO, JRNL AUTH 2 C.TRAVAGLINI-ALLOCATELLI,S.J.SADEGHI,P.DOMINICI,J.A.HERMOSO, JRNL AUTH 3 A.ASTEGNO JRNL TITL EVALUATING THE POTENTIAL OF NON-IMMUNOSUPPRESSIVE JRNL TITL 2 CYCLOSPORIN ANALOGS FOR TARGETING TOXOPLASMA GONDII JRNL TITL 3 CYCLOPHILIN: INSIGHTS FROM STRUCTURAL STUDIES. JRNL REF PROTEIN SCI. V. 33 E5157 2024 JRNL REFN ESSN 1469-896X JRNL PMID 39312281 JRNL DOI 10.1002/PRO.5157 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.JIMENEZ-FARACO,J.A.HERMOSO REMARK 1 TITL STRUCTURAL BASIS FOR CYCLOSPORIN ISOFORM-SPECIFIC INHIBITION REMARK 1 TITL 2 OF CYCLOPHILINS FROM TOXOPLASMA GONDII IN COMPLEX WITH REMARK 1 TITL 3 CYCLOSPORIN A AT 1.1 ANGSTROMS RESOLUTION REMARK 1 REF ACS INFECT DIS V. 9 365 2023 REMARK 1 REFN ESSN 2373-8227 REMARK 1 PMID 36653744 REMARK 1 DOI 10.1107/S2052252514009324 REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0405 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 125265 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.179 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 6317 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3916 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.2745 REMARK 3 BIN FREE R VALUE SET COUNT : 228 REMARK 3 BIN FREE R VALUE : 0.2744 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3235 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 617 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 13 B 301 REMARK 3 ORIGIN FOR THE GROUP (A): 8.9209 -22.7742 16.2366 REMARK 3 T TENSOR REMARK 3 T11: 0.0784 T22: 0.0837 REMARK 3 T33: 0.0929 T12: -0.0007 REMARK 3 T13: -0.0135 T23: -0.0035 REMARK 3 L TENSOR REMARK 3 L11: 0.6944 L22: 1.7997 REMARK 3 L33: 0.8710 L12: 0.0695 REMARK 3 L13: 0.1043 L23: 0.0302 REMARK 3 S TENSOR REMARK 3 S11: 0.0199 S12: -0.0289 S13: -0.0518 REMARK 3 S21: 0.1675 S22: -0.0041 S23: -0.1252 REMARK 3 S31: 0.0057 S32: 0.0004 S33: -0.0128 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 13 A 301 REMARK 3 ORIGIN FOR THE GROUP (A): -0.0851 -57.5832 7.5776 REMARK 3 T TENSOR REMARK 3 T11: 0.0811 T22: 0.0984 REMARK 3 T33: 0.0839 T12: -0.0036 REMARK 3 T13: 0.0011 T23: 0.0081 REMARK 3 L TENSOR REMARK 3 L11: 0.8520 L22: 2.0502 REMARK 3 L33: 0.6298 L12: 0.4255 REMARK 3 L13: 0.1236 L23: 0.0864 REMARK 3 S TENSOR REMARK 3 S11: 0.0027 S12: -0.0237 S13: 0.0546 REMARK 3 S21: 0.0304 S22: -0.0247 S23: -0.0299 REMARK 3 S31: -0.0356 S32: 0.0200 S33: 0.0201 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.10 REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8R7T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-DEC-23. REMARK 100 THE DEPOSITION ID IS D_1292134877. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-SEP-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979260 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 0.86 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.13 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 125282 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 42.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.0300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 1.00000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRIC ACID PH 3.5, AND 25% REMARK 280 POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 59.26000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ALISPORIVIR INHIBITS CYCLOPHILIN A, POTENTIALLY USEFUL TREATMENT OF REMARK 400 HEPATITIS C, AND NOT IMMUNOSUPPRESSIVE. REMARK 400 REMARK 400 THE ALISPORIVIR IS CYCLIC PEPTIDE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ALISPORIVIR REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: Analogue of cyclosporine A. It is a cyclic REMARK 400 undecapeptide. Cyclization is achieved by linking REMARK 400 the N- and the C- termini. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 PRO B 3 REMARK 465 ALA B 4 REMARK 465 PRO B 5 REMARK 465 PRO B 6 REMARK 465 ALA B 7 REMARK 465 ASN B 8 REMARK 465 SER B 9 REMARK 465 GLY B 10 REMARK 465 GLU B 11 REMARK 465 SER B 12 REMARK 465 GLY A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 PRO A 3 REMARK 465 ALA A 4 REMARK 465 PRO A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 ASN A 8 REMARK 465 SER A 9 REMARK 465 GLY A 10 REMARK 465 GLU A 11 REMARK 465 SER A 12 REMARK 465 ASN A 86 REMARK 465 GLN A 87 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 DAL C 1 C MLE C 2 N 0.187 REMARK 500 MLE C 2 C MLE C 3 N 0.189 REMARK 500 MLE C 3 C MVA C 4 N 0.154 REMARK 500 MVA C 4 C BMT C 5 N 0.162 REMARK 500 BMT C 5 C ABA C 6 N 0.151 REMARK 500 ABA C 6 C 33X C 7 N 0.154 REMARK 500 33X C 7 C 66E C 8 N 0.176 REMARK 500 66E C 8 C VAL C 9 N 0.169 REMARK 500 VAL C 9 C MLE C 10 N 0.155 REMARK 500 MLE C 10 C ALA C 11 N 0.177 REMARK 500 DAL D 1 C MLE D 2 N 0.167 REMARK 500 MLE D 2 C MLE D 3 N 0.139 REMARK 500 MLE D 3 C MVA D 4 N 0.144 REMARK 500 MVA D 4 C BMT D 5 N 0.161 REMARK 500 BMT D 5 C ABA D 6 N 0.142 REMARK 500 ABA D 6 C 33X D 7 N 0.153 REMARK 500 33X D 7 C 66E D 8 N 0.168 REMARK 500 66E D 8 C VAL D 9 N 0.154 REMARK 500 VAL D 9 C MLE D 10 N 0.159 REMARK 500 MLE D 10 C ALA D 11 N 0.165 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE B 104 -77.67 -130.29 REMARK 500 ARG B 119 54.51 -141.72 REMARK 500 CYS B 163 59.49 -142.26 REMARK 500 CYS B 163 55.55 -140.08 REMARK 500 PHE A 104 -77.63 -132.54 REMARK 500 CYS A 163 60.32 -153.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 598 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH B 599 DISTANCE = 6.64 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8R7S RELATED DB: PDB REMARK 900 8R7S CONTAINS THE SAME PROTEIN WITH NIM811 DBREF1 8R7T B 1 211 UNP A0A7J6KAD1_TOXGO DBREF2 8R7T B A0A7J6KAD1 1 211 DBREF1 8R7T A 1 211 UNP A0A7J6KAD1_TOXGO DBREF2 8R7T A A0A7J6KAD1 1 211 DBREF 8R7T C 1 11 PDB 8R7T 8R7T 1 11 DBREF 8R7T D 1 11 PDB 8R7T 8R7T 1 11 SEQADV 8R7T GLY B -1 UNP A0A7J6KAD EXPRESSION TAG SEQADV 8R7T HIS B 0 UNP A0A7J6KAD EXPRESSION TAG SEQADV 8R7T GLY A -1 UNP A0A7J6KAD EXPRESSION TAG SEQADV 8R7T HIS A 0 UNP A0A7J6KAD EXPRESSION TAG SEQRES 1 B 213 GLY HIS MET ALA PRO ALA PRO PRO ALA ASN SER GLY GLU SEQRES 2 B 213 SER SER LEU LEU SER GLU SER GLU LEU PRO ALA GLY ILE SEQRES 3 B 213 SER TYR ALA GLU ALA MET GLU GLY GLY SER ARG PRO LEU SEQRES 4 B 213 LEU HIS PRO ASP ASN PRO VAL VAL PHE PHE ASP ILE SER SEQRES 5 B 213 ILE GLY SER HIS GLU ALA GLY ARG ILE LYS ILE GLU LEU SEQRES 6 B 213 PHE LYS ASN LEU ALA PRO LYS SER ALA GLU ASN PHE ARG SEQRES 7 B 213 GLN PHE CYS THR GLY GLU PHE ARG GLN ASN GLN VAL PRO SEQRES 8 B 213 ILE GLY TYR LYS GLY ALA THR PHE HIS ARG ILE ILE LYS SEQRES 9 B 213 ASN PHE MET ILE GLN GLY GLY ASP PHE VAL LYS GLY ASP SEQRES 10 B 213 GLY THR GLY ARG LEU SER ILE TYR GLY SER SER PHE PRO SEQRES 11 B 213 ASP GLU ALA PHE VAL LEU PRO HIS PHE ARG SER GLY LEU SEQRES 12 B 213 LEU SER LEU ALA ASN SER GLY PRO ASP THR ASN GLY CYS SEQRES 13 B 213 GLN PHE PHE ILE THR CYS ALA LYS CYS ASP TRP LEU ASN SEQRES 14 B 213 ARG LYS HIS VAL VAL PHE GLY GLN VAL LEU GLY LYS GLU SEQRES 15 B 213 SER MET GLN VAL VAL ARG LYS ILE GLU HIS VAL THR VAL SEQRES 16 B 213 ASP GLY GLY ASN ARG PRO ARG ILE PRO VAL THR VAL THR SEQRES 17 B 213 GLN CYS GLY GLU LEU SEQRES 1 A 213 GLY HIS MET ALA PRO ALA PRO PRO ALA ASN SER GLY GLU SEQRES 2 A 213 SER SER LEU LEU SER GLU SER GLU LEU PRO ALA GLY ILE SEQRES 3 A 213 SER TYR ALA GLU ALA MET GLU GLY GLY SER ARG PRO LEU SEQRES 4 A 213 LEU HIS PRO ASP ASN PRO VAL VAL PHE PHE ASP ILE SER SEQRES 5 A 213 ILE GLY SER HIS GLU ALA GLY ARG ILE LYS ILE GLU LEU SEQRES 6 A 213 PHE LYS ASN LEU ALA PRO LYS SER ALA GLU ASN PHE ARG SEQRES 7 A 213 GLN PHE CYS THR GLY GLU PHE ARG GLN ASN GLN VAL PRO SEQRES 8 A 213 ILE GLY TYR LYS GLY ALA THR PHE HIS ARG ILE ILE LYS SEQRES 9 A 213 ASN PHE MET ILE GLN GLY GLY ASP PHE VAL LYS GLY ASP SEQRES 10 A 213 GLY THR GLY ARG LEU SER ILE TYR GLY SER SER PHE PRO SEQRES 11 A 213 ASP GLU ALA PHE VAL LEU PRO HIS PHE ARG SER GLY LEU SEQRES 12 A 213 LEU SER LEU ALA ASN SER GLY PRO ASP THR ASN GLY CYS SEQRES 13 A 213 GLN PHE PHE ILE THR CYS ALA LYS CYS ASP TRP LEU ASN SEQRES 14 A 213 ARG LYS HIS VAL VAL PHE GLY GLN VAL LEU GLY LYS GLU SEQRES 15 A 213 SER MET GLN VAL VAL ARG LYS ILE GLU HIS VAL THR VAL SEQRES 16 A 213 ASP GLY GLY ASN ARG PRO ARG ILE PRO VAL THR VAL THR SEQRES 17 A 213 GLN CYS GLY GLU LEU SEQRES 1 C 11 DAL MLE MLE MVA BMT ABA 33X 66E VAL MLE ALA SEQRES 1 D 11 DAL MLE MLE MVA BMT ABA 33X 66E VAL MLE ALA HET DAL C 1 5 HET MLE C 2 9 HET MLE C 3 9 HET MVA C 4 8 HET BMT C 5 13 HET ABA C 6 6 HET 33X C 7 6 HET 66E C 8 9 HET MLE C 10 9 HET DAL D 1 5 HET MLE D 2 9 HET MLE D 3 9 HET MVA D 4 8 HET BMT D 5 13 HET ABA D 6 6 HET 33X D 7 6 HET 66E D 8 9 HET MLE D 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM 33X N-METHYL-D-ALANINE HETNAM 66E N-ETHYL-L-VALINE FORMUL 3 DAL 2(C3 H7 N O2) FORMUL 3 MLE 6(C7 H15 N O2) FORMUL 3 MVA 2(C6 H13 N O2) FORMUL 3 BMT 2(C10 H19 N O3) FORMUL 3 ABA 2(C4 H9 N O2) FORMUL 3 33X 2(C4 H9 N O2) FORMUL 3 66E 2(C7 H15 N O2) FORMUL 5 HOH *617(H2 O) HELIX 1 AA1 SER B 16 LEU B 20 5 5 HELIX 2 AA2 SER B 25 GLU B 31 1 7 HELIX 3 AA3 ALA B 68 GLY B 81 1 14 HELIX 4 AA4 CYS B 163 ASN B 167 5 5 HELIX 5 AA5 GLY B 178 HIS B 190 1 13 HELIX 6 AA6 SER A 16 LEU A 20 5 5 HELIX 7 AA7 SER A 25 GLU A 31 1 7 HELIX 8 AA8 ALA A 68 GLY A 81 1 14 HELIX 9 AA9 CYS A 163 ASN A 167 5 5 HELIX 10 AB1 GLY A 178 HIS A 190 1 13 SHEET 1 AA1 8 PHE B 97 ILE B 101 0 SHEET 2 AA1 8 MET B 105 GLY B 108 -1 O GLN B 107 N ARG B 99 SHEET 3 AA1 8 PHE B 156 THR B 159 -1 O ILE B 158 N ILE B 106 SHEET 4 AA1 8 LEU B 141 LEU B 144 -1 N LEU B 141 O THR B 159 SHEET 5 AA1 8 VAL B 172 LEU B 177 -1 O GLY B 174 N LEU B 142 SHEET 6 AA1 8 HIS B 54 LEU B 63 -1 N GLU B 62 O GLN B 175 SHEET 7 AA1 8 VAL B 44 ILE B 51 -1 N ILE B 49 O ALA B 56 SHEET 8 AA1 8 VAL B 203 GLU B 210 -1 O GLN B 207 N ASP B 48 SHEET 1 AA2 2 ARG B 84 GLN B 85 0 SHEET 2 AA2 2 VAL B 88 PRO B 89 -1 O VAL B 88 N GLN B 85 SHEET 1 AA3 8 PHE A 97 ILE A 101 0 SHEET 2 AA3 8 MET A 105 GLY A 108 -1 O GLN A 107 N ARG A 99 SHEET 3 AA3 8 PHE A 156 THR A 159 -1 O ILE A 158 N ILE A 106 SHEET 4 AA3 8 LEU A 141 LEU A 144 -1 N SER A 143 O PHE A 157 SHEET 5 AA3 8 VAL A 172 LEU A 177 -1 O GLY A 174 N LEU A 142 SHEET 6 AA3 8 HIS A 54 LEU A 63 -1 N GLU A 62 O GLN A 175 SHEET 7 AA3 8 VAL A 44 ILE A 51 -1 N ILE A 49 O ALA A 56 SHEET 8 AA3 8 VAL A 203 GLU A 210 -1 O GLN A 207 N ASP A 48 LINK C DAL C 1 N MLE C 2 1555 1555 1.52 LINK N DAL C 1 C ALA C 11 1555 1555 1.51 LINK C MLE C 2 N MLE C 3 1555 1555 1.53 LINK C MLE C 3 N MVA C 4 1555 1555 1.49 LINK C MVA C 4 N BMT C 5 1555 1555 1.50 LINK C BMT C 5 N ABA C 6 1555 1555 1.49 LINK C ABA C 6 N 33X C 7 1555 1555 1.49 LINK C 33X C 7 N 66E C 8 1555 1555 1.51 LINK C 66E C 8 N VAL C 9 1555 1555 1.51 LINK C VAL C 9 N MLE C 10 1555 1555 1.49 LINK C MLE C 10 N ALA C 11 1555 1555 1.51 LINK C DAL D 1 N MLE D 2 1555 1555 1.50 LINK N DAL D 1 C ALA D 11 1555 1555 1.48 LINK C MLE D 2 N MLE D 3 1555 1555 1.48 LINK C MLE D 3 N MVA D 4 1555 1555 1.48 LINK C MVA D 4 N BMT D 5 1555 1555 1.50 LINK C BMT D 5 N ABA D 6 1555 1555 1.48 LINK C ABA D 6 N 33X D 7 1555 1555 1.49 LINK C 33X D 7 N 66E D 8 1555 1555 1.50 LINK C 66E D 8 N VAL D 9 1555 1555 1.49 LINK C VAL D 9 N MLE D 10 1555 1555 1.50 LINK C MLE D 10 N ALA D 11 1555 1555 1.50 CRYST1 38.312 118.520 46.535 90.00 103.53 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026101 0.000000 0.006281 0.00000 SCALE2 0.000000 0.008437 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022103 0.00000